Eruptive milia and comedones during treatment with dovitinib.

We report a case of eruptive facial milia and comedones in the setting of dovitinib treatment for metastatic gastrointestinal cancer. This case is unique as the clinical presentation was more rapid in onset and showed an absence of inflammatory lesions. Although the pathogenesis for skin manifestations is presently unknown, we present this case to increase awareness of potentially under-reported cutaneous side effects. PMID: 26437285 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/26437285?dopt=Abstract

Source: Dermatol Online J - October 9, 2015 Category: Dermatology Authors: Kimes K, Beasley K, Dalton SR Tags: Dermatol Online J Source Type: research